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Atrial thrombosis is a common lesion in female Taconic Swiss mice fed a high-fat
(28%), low-protein (8%), hypolipotropic diet for 10 wk or longer. After the third
week of such feeding the mice studied here were injected with either erythropoietin,
washed, packed red blood cells, lysed red blood cells, plasma or physiological saline.
In mice receiving injections of lysed red cells, plasma or saline, respectively 75,
54 and 82% of those surviving for 10 wk had developed atrial thrombosis. Hema-
tocrits were 9.3% or below in these groups. Hematocrits were maintained at an
average of 33.0% in the erythropoietin group and 32.4% in the transfused (packed
erythrocytes) group. Only one of the erythropoietin injected animals and none of
the transfused animals developed atrial thrombosis. The evidence indicates that the
anemia induced by the experimental diet results from lack of erythropoietin produc-
tion or activity and that the hypoxia of anemia plays a role in the development
of atrial thrombosis.
INTRODUCTION
A high incidence of atrial thrombosis and a concurrent severe anemia occur
in mice fed a high-fat, low-protein, hypolipotropic diet (1-4). As the anemia in-
creases in severity there is a concomitant rise in the incidence of atrial thrombosis.
When the hematocrit level was maintained at a near normal level by ip injections
of washed, packed red blood cells atrial thrombosis was prevented in mice fed
this atypical diet (4). Whether the antithrombogenic action of the transfused ery-
throcytes was due directly to their oxygen-transport capacity or to erythropoietic,
fibrinolytic or other activities remains undetermined.
Erythropoietin is known to initiate differentiation of the hemopoietic stem cell
into erythroblasts and may be involved in accelerating erythroblastic maturation
and the synthesis of hemoglobin. The exact cellular site(s) of production and bio-
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chemical mechanisms responsible for the action of erythropoietic factors are for
the most part unknown (5). Studies of the action of erythropoietin in certain clini-
cal erythropoietic disorders has provided information on the clinical problems and
pathogenesis associated with these diseases (5). The role of erythropoietin in the
diet-induced anemia of this study has heretofore not been determined.
The present study considers several aspects of the relation of erythrocytes and
anemia to this type of diet-induced atrial thrombosis. The effects on atrial thrombo-
sis of ip injections of erythropoietin, lysed erythrocytes and plasma were studied
in mice fed the thrombogenic diet. A major purpose was to identify participants
in the antithrombogenic process or activity.
MATERIALS AND METHODS
Portions of materials and methods used were as reported previously (4). Young,
adult, nulliparous mice of the Taconic Swiss (TS) stock with initial body weights
of 24-30 g and free of spontaneous cardiovascular diseases were used (6). Mice
receiving the experimental diet, ad lib., were housed in cages with a raised wire
mesh floor used to limit coprophagia. Within the mouse cages food was available
in metal containers constructed with partitions to restrict the mouse's contact with
the diet to its mouth and snout (7). The composition of the semipurified experi-
mental diet was 28% fat (lard), 8% protein (casein), and 57% sugar (sucrose)
supplemented with adequate amounts of vitamins and minerals and trace elements
except choline (2, 8-9).
Mice were divided into five groups: group 1 (ten mice) was fed the experimental
diet for 10 wk and in addition was injected daily beginning at the third week with
1.5 IU of erythropoietin (Step 1, Standard B-Connaught Medical Research Labora-
tories, University of Toronto) in 0.05 ml saline to maintain the hematocrit at ap-
proximately 30; group 2 (eight mice) received the experimental diet for 10 wk
and in addition was injected weekly beginning at the third week with 0.25-0.5 ml
of washed packed red cells as needed to maintain the hematocrit at approximately
30; group 3 (20 mice) received the experimental diet for 10 wk and in addition
was injected daily (0.05 ml) or weekly (0.5 ml) beginning at the third week with
lysed red cells; group 4 (19 mice) received the experimental diet for 10 wk and
in addition was injected daily (0.05 ml) or weekly (0.5 ml) beginning at the third
week with plasma; and group 5 (19 mice) received the experimental diet for 10
wk and in addition was injected daily (0.05 ml) or weekly (0.5 ml) beginning
at the third week with saline. Animals were weighed and hematocrits determined
weekly except for certain animals in the saline group (5) which developed closed,
swollen or severely scarred eyes early in the experiment. Incidence of atrial throm-
bosis in non-injected mice (Table 1) fed the diet used here has been reported
previously and included all animals which survived approximately 10 wk (4). Only
those animals surviving for the full duration of this experiment (10 wk) were used
for statistical purposes in Fig. 1 and Table 1.
Preparation of erythrocytes for injection has been described previously (4).
Heparinized blood (7-8 ml) from the postorbital sinus of donor TS mice was cen-
trifuged for 10 min at 2000 rpm and the plasma removed. The buffy coat was
removed and the erythrocytes suspended in a quantity of saline sufficient to make
15 ml. Washing of the erythrocytes was repeated three times. The washed, packed,
white blood cell (WBC)-free erythrocytes were injected ip into recipients.
Plasma removed from whole blood of donor mice that had not previously been
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bled was used. Washed, packed, WBC-free erythrocytes collected in the same man-
ner as those used for injection were frozen and thawed three times and then micro-
scopically examined for extent of lysis. Only occasional macrocytic erythrocytes
resisted this method of lysis.
Hearts were bisected at autopsy and after embedding in paraffin were sectioned
at 8 pm in a frontal plane with care to preserve the shape and position of the
atria. The PAS (periodic acid-Schiff's reagent) method plus hematoxylin and with
diastase hydrolysis was used to demonstrate atrial thrombosis and as a routine sur-
vey stain. Connective tissue stains included the silver method of Gordon and
Sweets, a combined PAS-silver method of Wilson et al., and the Mallory aniline
blue-acid fuschin method (10, 11).
Blood smears for microscopic examination were made from blood obtained from
the post-orbital sinus (12). Brecher's new methylene blue technique for reticulo-
cytes and Wright's stain technique were used to demonstrate reticulocytes and ery-
throcyte characteristics, respectively.
Erythropoietin was obtained from Connaught Medical Research Laboratories,
University of Toronto, Willowdale, Ontario, Canada. It is a Step 1 grade with a
potency of approximately 0.2-9.5 units/mg dry weight using the International Ref-
erence Preparation (Standard B) as a standard ( 13).
RESULTS
The results are summarized in Fig. 1 and Table 1. In those groups of mice (3,
4, 5) that received either a single large dose (0.5 ml) or daily small doses (0.05
ml) of injected material, the method of injection did not alter the results and they
are considered together.
Weight loss in animals that were fcd the experimental diet for 1l0 wk plus daily
or weekly injections of lysed red cells, plasma or saline was -24, -29 and --27%,
respectively. These data do not differ significantly from those of previous studies
using the same stock of mice and the same diet but without injections (1, 4). Ani-
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FIG. 1. Mean hematocrit valules (weekly) in mice fed the experimental diet plus injections
of erythropoietin, packed erythrocytes, lysed cells, plasma or saline.
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TABLE 1
INCIDENCE (%) OF ATILIAL THIROMBOSIS IN AMICE FED TIIE EXiEImMENTAL
DIET PLUS INJECTIONS OF E",RYTHROIPOIETIN, PACKED ERIYTHROCYTES,
LYSED CELLS, PLASMA OR SALINE,
Inci(leIiLe of
Number of atrial thrombosis
G1'o11) Trealtmlent illicC (%)
Erythropoieti 10( (10) Job
Packe(d erythrocytes 8 ( 8) ob
Lysed cells 0() ( 8) 75
4 Plasmria 19 (13) 54b
5 Salinie 19 (11)
a Nutimber of 1111Ce ill parenitieses survived the duration of the experimiielnt.
b Significaint differeiice (P < 0.05). Probability values were calculate(l witi reference to an 84%
inci(lence of atrial tllroIl)bosis ill 25 inoni-inijecte(l mice fed the experimilenital (liet for approximately
10 w-k (4).
mals that received injections of erythropoietin lost only -7% body weight and
those injected with erythrocytes had an increase of 4-6% in mean body weight.
Hematocrits of mice fed the experimental diet for 10 wk and given daily or
weekly injections of lysed red cells, plasma or saline decreased rapidly and declined
to a final mean level of 9.3% or less (Fig. 1). These data agree with those of
previous studies using the same stock of mice and the same diet but without injec-
tions (4, 14). The final mean hematocrit of mice in the erythropoietin-injected
mice was 33.0% and in the transfused group 32.4%. In the latter two groups,
it was attempted to maintain hematocrits at approximately 30%, however, unlike
the results of pilot studies, hematocrits of erythropoietin-injected mice leveled off
at slightly above 35% by the fifth week and in transfused mice increased erratically
from a fourth week level of 18.6% to the ninth week high of 36.0% (Fig. 1).
Only one of the ten erythropoietin-injected mice developed atrial thrombosis.
Erythropoictin injections failed to maintain the hematocrit at the proper level in
this animal. The hematocrit decreased to 22% after 4 wk and was 20% after 10
wk. The incidence of atrial thrombosis in groups 2-5 were 0, 75, 53 and 82%,
respectively (Table 1). Statistically, plasma-injected mice may have been protected
somewhat from atrial thrombosis compared to non-injected mice on the diet (Table
1), however no major increase in mean hematocrit values or other protective
mechanisms was evident (Fig. 1). Histological changes during the formation of
atrial thrombi have been described in detail previously and did not differ in this
study (4).
As anemia increased in severity a rapid decrease of reticulocyte formation oc-
curred in mice fed the experimental diet for 10 wk plus daily or weekly injections
of lysed red cells, plasma or saline (groups 3-5). In addition to the decrease in
reticulocytes the anemia was characterized by anisocytosis and hypochromia. Ball
and Westin also found reticulocytopenia in mice fed the experimental diet only
and demonstrated that the anemia was a microcytic and hypochromic type (3).
Some anisocytosis and hypochromia occurred in the erythropoietin-injected mice,
however, reticulocytosis occurred throughout the experimental period in response
to the erythropoietin injections.
In mice that received erythropoietin injections the spleens were enlarged. Heme
pigment was observed in most organs of mice injected with lysed red cells. A high
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incidence (55% ) of coronary thrombosis was observed in animals that received
injections of lysed red cells. This was unexpected since in numerous previous
studies using the same diet as fed here coronary thrombosis at the tenth week was
not a significant finding (1-4). Except those mentioned above, changes in other
organs of all the experimental groups were those expected in mice fed the diet
used here.
DISCUSSION
The results demonstrate that it is the viable red cell and its prevention of hypoxia
that is protective against thrombosis since neither plasma nor lysed cells increased
the hematocrit or prevented atrial thrombosis. The anemia (microcytic, hypo-
chromic) produced by feeding protein-deficient diets was readily reversed at any
stage with return to proper nutrition (15, 16). Hematocrits returned to normal
and atrial thrombosis was prevented in mice returned to a normal diet after being
fed the diet used here for a period sufficient to induce anemia and a high incidence
of atrial thrombosis (3).
In this study, lysed red cells were expected to have an erythropoietic effect
(17-19). Brown et al. injected normal and fasted, dehydrated rats with washed
lyophilized or freeze-thawed erythrocytes and obtained both a significant increase
in 59Fe incorporation and reticulocytosis (20). The erythropoietic stimulating activ-
ity was in the hemoglobin and heme-related compounds but not in the stroma or
globin fractions of the red cells. Here the lysed cell homogenate did not prevent
or correct the anemia of mice. Erythropoietic activity of red cell homogenates may,
therefore, be a species characteristic (19).
A fibrinolytic or thrombolytic effect of lysed red cells has been reported (21-22).
If thrombi develop by deposition of fibrin upon or under the endothelium (23-25)
or at sites of "endothelial rupture" (4) the red cell fibrinolytic system could alter
or prevent mural atrial thrombosis. Injection of lysed red cells of equal volume
and concentration as the intact red cell injections were not effective in preventing
atrial thrombosis. Thus, in this study hemolysis either destroyed the fibrinolytic
actions of the red cells or the fibrinolytic process plays no role in the prevention
of diet-induced atrial thrombosis (26).
Reissmann reported that protein deficiency anemia could be reversed by erythro-
poietin (16). Prior to this, it was shown that erythropoietin enhanced iron uptake
and heme synthesis in vitro (27-28). Exogenous erythropoietin injection over a
two wk period in preliminary studies by these authors (unpublished) reversed the
diet-induced anemia at any stage of the dietary period and at any hematocrit from
6.7% upward. This provides an hypothesis that decreased erythropoietin produc-
tion or activity was responsible for the anemic state which in turn predisposed
the animals to extreme hypoxia and subsequent endocardial damage and atrial
thrombosis. In this study erythropoietin-injected mice maintain a higher mean
hematocrit level than erythrocyte injected mice; however, the range was greater
and the one incidence of atrial thrombosis was from an animal that showed only
a weak response to erythropoietin.
Microscopic examination of the blood of the erythropoietin-injected animals
during the tenth week of the experiment demonstrated hypochromia of mature red
cells and numerous reticulocytes. Normally an increase in hemoglobin occurs con-
currently with red cell proliferation in erythropoietin-stimulated animals (29-30).
However, with time hemoglobin synthesis ceases to be a response to erythropoietin
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stimulation in animals severely deficient in essential nutrients (31 ). Erythro-
poietin-injected mice may be susceptible to atrial thrombosis not bccause of me-
chanical mechanisms (e.g., reduced circulating red cell mass) but because of a
decrease in hemoglobin synthesis even though the hematocrit is near normal. Here
massive hepatic liposis as a result or sequel of nutritional deficiencies may have
reduced hemoglobin formation.
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